Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12) 12
male (12) 12
adult (11) 11
female (11) 11
infectious diseases (10) 10
middle aged (9) 9
aids (7) 7
hiv infections - drug therapy (7) 7
immunology (7) 7
anti-hiv agents - therapeutic use (6) 6
hiv (6) 6
index medicus (6) 6
risk factors (6) 6
viral load (6) 6
cohort studies (5) 5
microbiology (5) 5
treatment outcome (5) 5
antiretroviral therapy, highly active (4) 4
cd4 lymphocyte count (4) 4
epidemiology (4) 4
hiv infections - epidemiology (4) 4
mortality (4) 4
virology (4) 4
aged (3) 3
analysis (3) 3
anti-hiv agents - adverse effects (3) 3
antiretroviral therapy (3) 3
drug therapy (3) 3
hiv infections - virology (3) 3
human immunodeficiency virus--hiv (3) 3
infection (3) 3
migrant (3) 3
research (3) 3
rna, viral - blood (3) 3
spain - epidemiology (3) 3
therapy (3) 3
adolescent (2) 2
adults (2) 2
care and treatment (2) 2
cd4 cell count (2) 2
clinical trials (2) 2
cohort (2) 2
cohort study (2) 2
cumulative incidence (2) 2
diagnosis (2) 2
diagnosis delay (2) 2
disease progression (2) 2
drug therapy, combination (2) 2
follow-up studies (2) 2
haart (2) 2
hepatitis-c (2) 2
hiv infection (2) 2
hiv infections - complications (2) 2
hiv infections - immunology (2) 2
hiv infections - transmission (2) 2
hiv-1 (2) 2
hiv-1 - isolation & purification (2) 2
human-immunodeficiency-virus (2) 2
incidence rate (2) 2
individuals (2) 2
infected patients (2) 2
infections (2) 2
medicine, general & internal (2) 2
men (2) 2
mitochondrial dna (2) 2
multivariate analysis (2) 2
nevirapine - therapeutic use (2) 2
population (2) 2
prospective studies (2) 2
prosthetic joint (2) 2
reverse-transcriptase inhibitors (2) 2
risk (2) 2
rna (2) 2
sex (2) 2
spain (2) 2
time factors (2) 2
toxicity (2) 2
transients and migrants - statistics & numerical data (2) 2
transmission (2) 2
trends (2) 2
tuberculosis (2) 2
1506 (1) 1
absorptiometry, photon (1) 1
acquired immune deficiency syndrome--aids (1) 1
acquired immunodeficiency syndrome - drug therapy (1) 1
acquired immunodeficiency syndrome - epidemiology (1) 1
acquired immunodeficiency syndrome - mortality (1) 1
active antiretroviral therapy (1) 1
adipocytes (1) 1
adipose-tissue (1) 1
adverse events (1) 1
aged, 80 and over (1) 1
aids/hiv (1) 1
alcohol (1) 1
alcohol beverage preference (1) 1
alcohol drinking - epidemiology (1) 1
alcoholic beverages (1) 1
alcoholic beverages - statistics & numerical data (1) 1
anti-hiv agents - administration & dosage (1) 1
anti-hiv agents - pharmacology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Estimating the HIV undiagnosed population in Catalonia, Spain: descriptive and comparative data analysis to identify differences in MSM stratified by migrant and Spanish-born population
by Reyes-Urueña, Juliana Maria and Campbell, Colin N J and Vives, Núria and Esteve, Anna and Ambrosioni, Juan and Tural, Cristina and Ferrer, Elena and Navarro, Gemma and Force, Lluis and García, Isabel and Masabeu, Àngels and Vilaró, Josep M and García de Olalla, Patricia and Caylà, Joan Artur and Miró, Josep M and Casabona, Jordi and PISCIS Investigators and PISCIS investigators
BMJ Open, ISSN 2044-6055, 02/2018, Volume 8, Issue 2, p. e018533
ObjectiveUndiagnosed HIV continues to be a hindrance to efforts aimed at reducing incidence of HIV. The objective of this study was to provide an estimate of... 
HIV undiagnosed infection | HIV surveillance | migrant | continuum of care | cascade | MSM | UNITED-STATES | MEDICINE, GENERAL & INTERNAL | TRANSMISSION | VIRUS | SURVEILLANCE DATA | PERSONS AWARE | MEN | SEX | RISK | INFECTION | CARE | HIV Infections - epidemiology | Humans | Risk Factors | Male | CD4 Lymphocyte Count | Models, Statistical | Forecasting | Spain - epidemiology | HIV Infections - diagnosis | Adult | Female | HIV Infections - transmission | Transients and Migrants - statistics & numerical data | Homosexuality, Male - statistics & numerical data | Data analysis | Acquired immune deficiency syndrome--AIDS | Surveillance | Human immunodeficiency virus--HIV | Sexual behavior | Population | Medical tests | Infections | Drug therapy | Estimates | Public health
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Improvement of Mitochondrial Toxicity in Patients Receiving a Nucleoside Reverse-Transcriptase Inhibitor–Sparing Strategy: Results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA)
by Eugenia Negredo and Òscar Miró and Benjamí Rodríguez-Santiago and Glòria Garrabou and Carla Estany and Àngels Masabeu and Lluís Force and Pilar Barrufet and Josep Cucurull and Pere Domingo and Carlos Alonso-Villaverde and Anna Bonjoch and Constanza Morén and Núria Pérez-Alvarez and Bonaventura Clotet and MULTINEKA Study Grp and MULTINEKA Study Group
Clinical Infectious Diseases, ISSN 1058-4838, 9/2009, Volume 49, Issue 6, pp. 892 - 900
Background. Nucleoside reverse-transcriptase inhibitor (NRTI)–related mitochondrial toxicity has been suggested as a key factor in the induction of... 
Control groups | Antiretrovirals | HIV infections | HIV | Nucleosides | Hospital units | Lipodystrophy | Mitochondrial DNA | Reverse transcriptase inhibitors | Fats | ARTICLES AND COMMENTARIES | INFECTIOUS DISEASES | ADIPOCYTES | ANTIRETROVIRAL-THERAPY | HAART-RELATED LIPODYSTROPHY | MICROBIOLOGY | IMMUNOLOGY | PERIPHERAL LIPOATROPHY | BLOOD MONONUCLEAR-CELLS | HIV-INFECTED PATIENTS | DNA DEPLETION | THERAPY-RELATED LIPODYSTROPHY | KEY FACTOR | ADIPOSE-TISSUE | Follow-Up Studies | Humans | Middle Aged | Male | Nevirapine - therapeutic use | DNA, Mitochondrial - analysis | Viral Load | Electron Transport Complex IV - metabolism | Reverse Transcriptase Inhibitors - adverse effects | Body Composition - drug effects | Lipids - blood | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Extremities | Anti-HIV Agents - adverse effects | HIV-Associated Lipodystrophy Syndrome - chemically induced | Lopinavir | Pyrimidinones - therapeutic use | Treatment Outcome | Absorptiometry, Photon | Antiretroviral Therapy, Highly Active | HIV-Associated Lipodystrophy Syndrome - pathology | HIV Infections - drug therapy | HIV-Associated Lipodystrophy Syndrome - metabolism | HIV Infections - metabolism | Usage | Care and treatment | Nevirapine | Bone densitometry | Dosage and administration | Mitochondrial diseases | Research | HIV infection | Risk factors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection
by David Nicolás and Anna Esteve and Anna Cuadros and Colin N J Campbell and Cristina Tural and Daniel Podzamczer and Javier Murillas and Francesc Homar and Ferrán Segura and Lluis Force and Josep Vilaró and Àngels Masabeu and Isabel Garcia and Jordi Mercadal and Alexandra Montoliu and Elena Ferrer and Melcior Riera and Carmen Cifuentes and Juan Ambrosioni and Gemma Navarro and Christian Manzardo and Bonaventura Clotet and Josep M Gatell and Jordi Casabona and José M Miró
Clinical Infectious Diseases, ISSN 1058-4838, 06/2016, Volume 62, Issue 12, p. 1578
  It has been suggested that routine CD4 cell count monitoring in human immunodeficiency virus (HIV)-monoinfected patients with suppressed viral loads and CD4... 
Human papillomavirus | Human immunodeficiency virus--HIV | Probability | Glycoproteins | Immune system
Journal Article
Details down arrow
4. Full Text Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients with HIV Infection or HIV/Hepatitis C Virus Coinfection
by Nicolás, David and Esteve, Anna and Cuadros, Anna and Campbell, Colin N. J and Tural, Cristina and Podzamczer, Daniel and Murillas, Javier and Homar, Francesc and Segura, Ferrán and Force, Lluis and Vilaró, Josep and Masabeu, Àngels and Garcia, Isabel and Mercadal, Jordi and Montoliu, Alexandra and Ferrer, Elena and Riera, Melcior and Cifuentes, Carmen and Ambrosioni, Juan and Navarro, Gemma and Manzardo, Christian and Clotet, Bonaventura and Gatell, Josep M and Casabona, Jordi and Miró, José M and PISCIS Cohort Study Investigators
Clinical Infectious Diseases, ISSN 1058-4838, 06/2016, Volume 62, Issue 12, pp. 1578 - 1585
Background. It has been suggested that routine CD4 cell count monitoring in human immunodeficiency virus (HIV)-monoinfected patients with suppressed viral... 
CD4 cell count | HIV-1 | HIV-1/HCV coinfection | HIV-1 suppression | INFECTIOUS DISEASES | SEX | MICROBIOLOGY | ANTIRETROVIRAL THERAPY | TIME | IMMUNOLOGY | HEPATITIS | MEN | COHORT | PROGRESSION | Coinfection - immunology | HIV Infections - epidemiology | HIV Infections - virology | Humans | Middle Aged | Male | Coinfection - epidemiology | Coinfection - virology | Viral Load | CD4-Positive T-Lymphocytes - immunology | Young Adult | HIV Infections - immunology | Hepatitis C - immunology | Hepatitis C - epidemiology | Adolescent | HIV Infections - complications | Hepatitis C - virology | Adult | Female | Hepatitis C - complications | Hepacivirus | Cohort Studies | Hepatitis | HIV patients | Care and treatment | CD4 lymphocytes | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Didanosine, Lamivudine, and Efavirenz versus Zidovudine, Lamivudine, and Efavirenz for the Initial Treatment of HIV Type 1 Infection: Final Analysis (48 Weeks) of a Prospective, Randomized, Noninferiority Clinical Trial, GESIDA 3903
by Juan Berenguer and Juan González and Esteban Ribera and Pere Domingo and Jesús Santos and Pilar Miralles and Ma. Angels Ribas and Víctor Asensi and Juan Luis Gimeno and José Antonio Pérez-Molina and José Alberto Terrón and Juan Miguel Santamaría and Enric Pedrol and GESIDA 3903 Team
Clinical Infectious Diseases, ISSN 1058-4838, 10/2008, Volume 47, Issue 8, pp. 1083 - 1092
Background. The combination of didanosine, lamivudine, and efavirenz (ddI/3TC/EFV) for the initial treatment of human immunodeficiency virus type 1 (HIV-1)... 
HIV/AIDS | Hospitals | RNA | Writing tablets | Clinical trials | AIDS | Medications | Infections | Genetic mutation | HIV 1 | Virology | INFECTIOUS DISEASES | ADULTS | ENTERIC-COATED BEADS | MICROBIOLOGY | SEQUENTIAL 3-DRUG REGIMENS | IMMUNOLOGY | STAVUDINE | INDIVIDUALS | THERAPY | PHARMACOKINETICS | RECOMMENDATIONS | SOCIETY-USA PANEL | Didanosine - therapeutic use | Lamivudine - administration & dosage | Prospective Studies | Didanosine - adverse effects | Humans | Middle Aged | Male | RNA, Viral - blood | Viral Load | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Lamivudine - adverse effects | HIV-1 - isolation & purification | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Severity of Illness Index | Benzoxazines - administration & dosage | Zidovudine - adverse effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Benzoxazines - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Benzoxazines - therapeutic use | Antiretroviral Therapy, Highly Active | Didanosine - administration & dosage | HIV Infections - drug therapy | Zidovudine - therapeutic use | Drug therapy, Combination | Research | Drug therapy | HIV infection | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Improvement of Mitochondrial Toxicity in Patients Receiving a Nucleoside Reverse-Transcriptase Inhibitor-Sparing Strategy: Results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA)
by Eugenia Negredo and Òscar Miró and Benjamí Rodríguez-Santiago and Glòria Garrabou and Carla Estany and Àngels Masabeu and Lluís Force and Pilar Barrufet and Josep Cucurull and Pere Domingo and Carlos Alonso-Villaverde and Anna Bonjoch and Constanza Morén and Núria Pérez-Álvarez and Bonaventura Clotet
Clinical Infectious Diseases, ISSN 1058-4838, 09/2009, Volume 49, Issue 6, p. 892
  Nucleoside reverse-transcriptase inhibitor (NRTI)-related mitochondrial toxicity has been suggested as a key factor in the induction of... 
Inhibitor drugs | Body fat | Toxicity | Clinical trials | Mitochondrial DNA | Comparative analysis
Journal Article
Details down arrow
7. Full Text Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) Study
by Munoz-Moreno, J.A and Fumaz, C.R and Ferrer, M.J and Tula, A and Rovira, T and Vilaich, C and Bayes, R and Burger, D.M and Negredo, E and Clotet, B and SERAD Validation Team and the SERAD Validation Team
AIDS Research and Human Retroviruses, ISSN 0889-2229, 2007, Volume 23, Issue 10, pp. 1166 - 1175
The relationship between adherence to highly active antiretroviral therapy (HAART) and RNA-HIV viral load outcomes has been extensively shown. Although there... 
VIRAL LOAD | RATES | INFECTIOUS DISEASES | VIROLOGY | EFFICACY | ACTIVE ANTIRETROVIRAL THERAPY | AIDS | DEATH | IMMUNOLOGY | Antiretroviral Therapy, Highly Active | Pilot Projects | Humans | Middle Aged | Adult | Female | HIV Infections - drug therapy | Male | Surveys and Questionnaires | Treatment Outcome | Patient Compliance | Cohort Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Características clinicoepidemiológicas y tendencias en el tratamiento antirretroviral de una cohorte de pacientes con infección por el virus de la inmunodeficiencia humana. Cohorte PISCIS
by Jaén, Ángeles and Casabona, Jordi and Esteve, Anna and Miró, Jose M and Tural, Cristina and Ferrer, Elena and Riera, Melchor and Segura, Ferran and Force, Lluís and Sued, Omar and Vilaró, Josep and Masabeu, Ángels and García, Isabel and Dorca, Esther and Altès, Jordi and Navarro, Gemma and Podzamczer, Daniel and Villalonga, Concepción and Clotet, Bonaventura and Gatell, Josep M
Medicina Clinica, ISSN 0025-7753, 04/2005, Volume 124, Issue 14, pp. 525 - 531
Trends | HIV | Oiagnosis delay | Epidemiology | Cohort study | HAART
Journal Article
Details down arrow
9. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005
by Romero, Anabel and Sued, Omar and Puig, Teresa and Esteve, Anna and Pumarola, Tomàs and Casabona, Jordi and González, Victoria and Matas, Lurdes and Tural, Cristina and Rodrigo, Isabel and Margall, Núria and Domingo, Pere and Casanova, Aurora and Ferrer, Elena and Caballero, Estrella and Ribera, Esteve and Farré, Joan and Amengual, M. José and Navarro, Gemma and Prat, Josep M and Masabeu, Àngels and Simó, Josep M and Villaverde, Carlos A and Barrufet, Pilar and Sauca, M. Goretti and Ortin, Xavier and Ortí, Amat and Navarro, Rosa and Euras, Josep M and Vilaró, Josep and Villà, M. Carme and Montull, Santiago and Vilanova, Conrad and Pujol, Ferran and Díaz, Olga and Miró, Jose M and AERI Study Grp and AERI study Group
Enfermedades Infecciosas y Microbiologia Clinica, ISSN 0213-005X, 08/2011, Volume 29, Issue 7, pp. 482 - 489
Objectives: The objectives of this study were to assess the prevalence of transmitted HIV-1 drug resistances (TDR) and HIV-1 subtypes in recently infected... 
Transmitted resistance | HIV-1 subtypes | Recent infections | GENOTYPIC RESISTANCE | INFECTIOUS DISEASES | VARIANTS | MICROBIOLOGY | DRUG-RESISTANCE | INDIVIDUALS | EUROPE | TRANSMISSION | REVERSE-TRANSCRIPTASE INHIBITORS | THERAPY | NON-B SUBTYPES | MUTATIONS | Anti-HIV Agents - pharmacology | HIV Infections - epidemiology | Humans | HIV Protease - genetics | HIV Reverse Transcriptase - genetics | Male | Specimen Handling | RNA, Viral - genetics | Genes, pol | HIV-1 - isolation & purification | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - transmission | Retrospective Studies | Emigrants and Immigrants | Drug Resistance, Multiple, Viral - genetics | HIV-1 - drug effects | HIV Infections - virology | Genotype | HIV-1 - genetics | Drug Resistance, Viral - genetics | Sequence Analysis, RNA | Spain - epidemiology | HIV Infections - drug therapy | Mutation | Population Surveillance | Genes, rev
Journal Article
Details down arrow
10. Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection
by Nicolas, David and Esteve, Anna and Cuadros, Anna and Campbell, Colin N J and Tural, Cristina and Podzamczer, Daniel and Murillas, Javier and Homar, Francesc and Segura, Ferran and Force, Lluis and Vilaro, Josep and Masabeu, Angels and Garcia, Isabel and Mercadal, Jordi and Montoliu, Alexandra and Ferrer, Elena and Riera, Melcior and Cifuentes, Carmen and Ambrosioni, Juan and Navarro, Gemma and Manzardo, Christian and Clotet, Bonaventura and Gatell, Josep M and Casabona, Jordi and Miro, Jose M
Clinical Infectious Diseases, ISSN 1058-4838, 06/2016, Volume 62, Issue 12, pp. 1578 - 1578
It has been suggested that routine CD4 cell count monitoring in human immunodeficiency virus (HIV)-monoinfected patients with suppressed viral loads and CD4... 
Journal Article
Details down arrow
11. Full Text Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort
by Llibre, JM and Montoliu, A and Miró, JM and Domingo, P and Riera, M and Tiraboschi, J and Curran, A and Homar, F and Ambrosioni, J and Abdulghani, N and Force, L and Peraire, J and Casabona, J and Vilaró, Joaquim and Masabeu, Angels and Orti, Amat J and Dalmau, David and Reyes, Juliana and Bruguera, Andreu and Montoliu, Alexandra and Muntada, Esteve and Podzamczer, D and Navarro, G and Cortés, C and Falcó, V and Mallolas, J and Manzardo, C and Imaz, A and Burgos, J and Gracia Mateo, M and Gutierrez, M. M and Murillas, J and Segura, F and García‐Gasalla, M and Puig, T and Vidal, F and Leon, E and Jaen, À and Almuedo, A and De Lazzari, E and Giralt, D and Martin, M and Gargoulas, F and Vanrell, T and Rubia, J. C and Vilà, J and Ferrés, M and Morell, B and Tamayo, M and Laguno, M and Martínez, M and Blanco, J. L and Garcia‐Alcaide, F and Martínez, E and Jou, A and Clotet, B and Saumoy, M and Silva, A and Prieto, P and Navarro, J and Ribera, Esteve and Gurgui, M and Ribas, M. A and Campins, A. A and Fanjul, F. J and Leyes, M and Peñaranda, M and Martin, L and Vilchez, H and Calzado, S and Cervantes, M and Amengual, J and Navarro, M and Payeras, T and Cifuentes, C and Comella, T and Vargas, M and Viladés, C and Barrufet, P and Chivite, I and Chamarro, E and Escrig, C and Cairó, M and Martinez‐Lacasa, X and Font, R and Deig, E and Meyer, S and Hernandez, J and PISCIS Cohort Grp and PISCIS Cohort group
HIV Medicine, ISSN 1464-2662, 03/2019, Volume 20, Issue 3, pp. 237 - 247
Objectives The aim of the study was to assess the rates of discontinuation of integrase inhibitor regimens because of any neuropsychiatric adverse event (NPAE)... 
raltegravir | integrase strand transfer inhibitors | adverse events | dolutegravir | neuropsychiatric toxicity | elvitegravir/cobicistat | INFECTIOUS DISEASES | ONCE-DAILY DOLUTEGRAVIR | INITIAL TREATMENT | CLINICAL-EXPERIENCE | NON-INFERIORITY | TENOFOVIR DISOPROXIL FUMARATE | DOUBLE-BLIND | COMBINATION ANTIRETROVIRAL THERAPY | INTEGRASE INHIBITOR | NAIVE ADULTS | Medicine, Experimental | Antiviral agents | Complications and side effects | Medical research | RNA | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS cohort (Spain)
by Jaén, Ángeles and Esteve, Anna and Miró, Josep M and Tural, Cristina and Montoliu, Alexandra and Ferrer, Elena and Riera, Melcior and Segura, Ferran and Force, Lluis and Sued, Omar and Vilaró, Josep and Garcia, Isabel and Masabeu, Angels and Altès, Jordi and Clotet, Bonaventura and Podzamczer, Daniel and Murillas, Javier and Navarro, Gemma and Gatell, Josep M and Casabona, Jordi and Casabona, J and Esteve, Anna and Jaén, Ángeles and Granell, M and Gatell, J.M and Miró, J.M and Murillas, J and Riera, S and Podzamcer, D and Ferrer, E and Clotet, B and Tural, Cristina and Segura, F and Navarro, G and Force, L and Vilaró, J and Masabeu, A and García, I and Altés, J and Piscis Study Grp and PISCIS Study Group
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 02/2008, Volume 47, Issue 2, pp. 212 - 220
Objective: We analyze the factors related to progression to AIDS or death in HIV-infected patients from the Proyecto para la Informatizacion del Seguimiento... 
Lead time | PISCIS cohort | Highly active antiretroviral therapy | HIV disease progression | When to start highly active antiretroviral therapy | Hepatitis C virus | CD4 T-cell count | VIRAL LOAD | SURVIVAL | when to start highly active antiretroviral therapy | INFECTIOUS DISEASES | COLLABORATIVE ANALYSIS | AIDS | IMMUNOLOGY | CD4 CELL COUNT | CLINICAL PROGRESSION | HEPATITIS-C VIRUS | hepatitis C virus | highly active antiretroviral therapy | INFECTED PATIENTS | GENDER-DIFFERENCES | lead time | DISEASE PROGRESSION | Humans | Middle Aged | Male | RNA, Viral - blood | Treatment Outcome | CD4 Lymphocyte Count | Disease Progression | Viral Load | Spain | Antiretroviral Therapy, Highly Active | HIV Infections - immunology | Adolescent | HIV Infections - complications | Aged, 80 and over | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Aged | Hepatitis C | Cohort Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Higher rates of AIDS during the first year of antiretroviral therapy among migrants: The importance of tuberculosis: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
by Shepherd, Bryan E and Jenkins, Cathy A and Parrish, Deidra D and Glass, Tracy R and Cescon, Angela and Masabeu, Angels and Chene, Genevieve and De Wolf, Frank and Crane, Heidi M and Jarrin, Inma and Gill, John and Del Amo, Julia and Abgrall, Sophie and Khaykin, Pavel and Lehmann, Clara and Ingle, Suzanne M and May, Margaret T and Sterne, Jonathan A.C and Sterling, Timothy R
AIDS, ISSN 0269-9370, 05/2013, Volume 27, Issue 8, pp. 1321 - 1329
AIDS | Tuberculosis | HIV | Migrant | Mortality | Antiretroviral therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis
by Shepherd, Bryan Shepherd and Jenkins, Cathy A and Parrish, Deia D and Glass, Tracy R and Cescon, Angela and Masabeu, Angels and Chene, Genevieve and de Wolf, Frank and Crane, Heidi M and Jarrin, Inma and Gill, John and del Amo, Julia and Abgrall, Sophie and Khaykin, Pavel and Lehmann, Clara and Ingle, Suzanne M and May, Margaret T and Sterne, Jonathan A. C and Sterling, Timothy R and Brodt, Hans-Reinhard and Casabona, Jordi and Cavassini, Matthias and Chêne, Geneviève and Costagliola, Dominique and Dabis, François and Monforte, Antonella D.'Arminio and Fätkenheuer, Gerd and Guest, Jodie and Haerry, David Hans-Ulrich and Hogg, Robert and Justice, Amy and Mocroft, Amanda and Kitahata, Mari and Lampe, Fiona and Reiss, Peter and Saag, Michael and Sterling, Tim and Williams, Matthew and Zangerle, Robert and Sterne, Jonathan and May, Margaret and Ingle, Suzanne and Antiretroviral Therapy Cohort Collaboration (ART-CC)
AIDS (London, England), ISSN 0269-9370, 2013, Volume 27, Issue 8, pp. 1321 - 1329
In lower-income countries rates of AIDS-defining events (ADEs) and death are high during the first year of combination antiretroviral therapy (ART). We... 
INFECTIOUS DISEASES | RISK-FACTORS | antiretroviral therapy | tuberculosis | PREVENTION | RIFAMPIN | AIDS | HIV-1-INFECTED PATIENTS | IMMUNOLOGY | HIV-INFECTION | VIROLOGY | HIV | migrant | mortality | COHORT | DEFINING EVENTS | ATAZANAVIR | DISEASE PROGRESSION | Humans | Middle Aged | Male | Survival Rate | Tuberculosis, Pulmonary - drug therapy | Acquired Immunodeficiency Syndrome - drug therapy | Developed Countries | Time Factors | Tuberculosis, Pulmonary - mortality | Acquired Immunodeficiency Syndrome - epidemiology | Acquired Immunodeficiency Syndrome - mortality | Adult | Anti-HIV Agents - therapeutic use | Female | Developing Countries | Transients and Migrants - statistics & numerical data | Tuberculosis, Pulmonary - epidemiology | Antiretroviral Therapy, Highly Active - methods | Cohort Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Proyecto REGICE. Gestión clínica de las unidades de corta estancia en España (REGICE 2)
by Llopis Roca, Ferrán and Ferré Losa, Carles and Juan Pastor, Antoni and Martín Sánchez, Francisco Javier and Sempere Montes, Gonzalo and Llorens Soriano, Pere and Navarro Bustos, Carmen and Martínez Ortiz de Zárate, Mikel and Sanpedro, Francesc and Guardiola, Josep María and Guzmán, Marta and Álvarez, Ana and Arranz, María and Daza, Manuel and Cortés, Emilia and José Rallo, María and Requena, Jordi and Pérez, Víctor and Masabeu, Àngels and Rúa, Aurora and Serra, Pere and Guerrero, Federico and Núñez, José Carlos and Lull, José Antonio and Ballester, Manuel and Palau, Pilar and Almela, Amadeo and Nieto, Ángel and Guirao, Ramón and Segarra, Mar and Hernández, María Encarna and Calderón, Juan Vicente and Anduiza, Juan and Martín, Alfonso and Juárez, Ricardo and Gil, Javier and Costa, Asunción and Ferreira, Antonio and Lapuerta, Luis and Soto, Basilio and Castro, Carlos and Porras, Antonio and Larruskain, Juan and Lisa, Valentín and Marco, Pedro and González, Arturo and García, Manuel and De La Fuente, Javier and Alfonso, Joaquín
Emergencias, ISSN 1137-6821, 10/2014, Volume 26, Issue 5, pp. 359 - 362
Short-stay unit | REGICE project | Emergency health services
Journal Article
Details down arrow
16. Full Text Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients
by Bonjoch, Anna and Paredes, Roger and Domingo, Pere and Cervantes, Manel and Pedrol, Enric and Ribera, Esteve and Force, Lluís and Llibre, Josep M and Vilaró, Josep and Dalmau, David and Cucurull, Josep and Mascaró, Jaume and Masabeu, Angels and Pérez-Álvarez, Núria and Puig, Jordi and Cinquegrana, Denise and Clotet, Bonaventura
AIDS Research and Human Retroviruses, ISSN 0889-2229, 04/2006, Volume 22, Issue 4, pp. 321 - 329
Using a multicenter, cross-sectional, observation study, the long-term safety, metabolic profile, and viral efficacy of nevirapine (NVP)- based approaches in... 
INFECTIOUS DISEASES | TOXICITY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | PROTEASE INHIBITORS | REVERSE-TRANSCRIPTASE INHIBITORS | VIROLOGY | NAIVE PATIENTS | EFAVIRENZ | INFECTED PATIENTS | HEPATOTOXICITY | CONTAINING ANTIRETROVIRAL THERAPY | HEPATITIS-C | HIV-1 | Follow-Up Studies | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Male | Nevirapine - therapeutic use | RNA, Viral - blood | Treatment Outcome | CD4 Lymphocyte Count | Clinical Trials as Topic | Chi-Square Distribution | Nevirapine - adverse effects | Viral Load | Cross-Over Studies | Time Factors | Cholesterol, HDL - blood | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Myocardial infarction and alcohol consumption: A population-based case-control study
by Schröder, Helmut and Masabeu, Angels and Marti, Maria Josep and Cols, Montserrat and Lisbona, Josep Maria and Romagosa, Cristina and Carión, Teresa and Vilert, Esther and Marrugat, Jaume and REGICOR Investigators and REGICOR investigators
Nutrition, Metabolism and Cardiovascular Diseases, ISSN 0939-4753, 2006, Volume 17, Issue 8, pp. 609 - 615
Abstract Background and aim Coronary heart disease (CHD) is the leading cause of death in industrialized societies. Identifying and characterizing modifiable... 
Cardiovascular | Wine | Alcohol | Beverage type | Alcohol beverage preference | Coronary heart disease | alcohol | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | disease | DRINKING | RISK | CORONARY HEART-DISEASE | FRENCH PARADOX | alcohol beverage preference | PHYSICAL-ACTIVITY QUESTIONNAIRE | BEVERAGE PREFERENCE | NUTRITION & DIETETICS | ENDOCRINOLOGY & METABOLISM | beverage type | coronary heart | RED WINE | HEALTH | wine | EPIDEMIOLOGY | Multivariate Analysis | Confidence Intervals | Life Style | Myocardial Infarction - epidemiology | Alcoholic Beverages - statistics & numerical data | Humans | Middle Aged | Risk Factors | Logistic Models | Male | Case-Control Studies | Beer | Alcohol Drinking - epidemiology | Adult | Aged | Myocardial Infarction - prevention & control | Odds Ratio | Myocardial Infarction - etiology | Alcoholic beverages | Ethylene glycol | Lactate dehydrogenase | Drinking of alcoholic beverages | Analysis | Heart attack
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights